Celyad announces third quarter 2016 business update

Celyad announces third quarter 2016 business update

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1): Clinical Trial Primary Outcomes

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1): Clinical Trial Primary Outcomes

Celyad Reports First Half 2016 Financial Results and Operational Progress

Celyad Reports First Half 2016 Financial Results and Operational Progress

Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD. to develop allogeneic NKR-2 T-cell immunotherapy

Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD. to develop allogeneic NKR-2 T-cell immunotherapy

Celyad announces first quarter 2016 business update

Celyad announces first quarter 2016 business update

Celyad reports 2015 Financial and Operating results

Celyad reports 2015 Financial and Operating results

Celyad Announces 2016 Financial Calendar

Celyad Announces 2016 Financial Calendar